ArticleSignal transduction and targeted therapy2021

PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma.

Qin Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.